Literature DB >> 27565673

Comparative analysis of L-sorbose dehydrogenase by docking strategy for 2-keto-L-gulonic acid production in Ketogulonicigenium vulgare and Bacillus endophyticus consortium.

Si Chen1,2, Nan Jia1,2, Ming-Zhu Ding3,4, Ying-Jin Yuan1,2.   

Abstract

Improving the yield of 2-keto-L-gulonic acid (2-KGA), the direct precursor of vitamin C, draws more and more attention in industrial production. In this study, we try to increase the 2-KGA productivity by computer-aided selection of genes encoding L-sorbose dehydrogenases (SDH) of Ketogulonicigenium vulgare. First, six SDHs were modeled by docking strategy to predict the binding mode with co-factor PQQ. The binding energy between SSDA1-H/SSDA1-L and PQQ was the highest, followed by SSDA3/SSDA2. The binding energy between SSDA1-P/SSDB and PQQ was the lowest. Then, these genes were overexpressed, respectively, in an industrial strain K. vulgare HKv604. Overexpression of ssda1-l and ssda1-h enhanced the 2-KGA production by 7.89 and 12.56 % in mono-cultured K. vulgare, and by 13.21 and 16.86 % when K. vulgare was co-cultured with Bacillus endophyticus. When the engineered K. vulgare SyBE_Kv000116013 (overexpression of ssda1-p) or SyBE_Kv000116016 (overexpression of ssdb) was co-cultured with B. endophyticus, the 2-KGA production decreased significantly. The docking results were in accordance with the experimental data, which indicated that computer-aided modeling is an efficient strategy for screening more efficient enzymes.

Entities:  

Keywords:  2-keto-L-gulonic acid; Bacillus endophyticus; Ketogulonicigenium vulgare; Microbial consortium

Mesh:

Substances:

Year:  2016        PMID: 27565673     DOI: 10.1007/s10295-016-1829-4

Source DB:  PubMed          Journal:  J Ind Microbiol Biotechnol        ISSN: 1367-5435            Impact factor:   3.346


  40 in total

Review 1.  Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.

Authors:  F Ooms
Journal:  Curr Med Chem       Date:  2000-02       Impact factor: 4.530

2.  Complete genome sequence of the bacterium Ketogulonicigenium vulgare Y25.

Authors:  Xiang-hua Xiong; Shuang Han; Jian-hua Wang; Ze-hui Jiang; Wei Chen; Ning Jia; Hong-li Wei; Hong Cheng; Yan-xin Yang; Bin Zhu; Song You; Jian-yong He; Wei Hou; Meng-xia Chen; Chun-jie Yu; Ying-hui Jiao; Wei-cai Zhang
Journal:  J Bacteriol       Date:  2010-10-29       Impact factor: 3.490

3.  Crystal structure of L-sorbose dehydrogenase, a pyrroloquinoline quinone-dependent enzyme with homodimeric assembly, from Ketogulonicigenium vulgare.

Authors:  Xiaodong Han; Xianghua Xiong; Dunquan Jiang; Sihan Chen; Enyu Huang; Weicai Zhang; Xinqi Liu
Journal:  Biotechnol Lett       Date:  2014-02-21       Impact factor: 2.461

4.  Design and characterization of synthetic fungal-bacterial consortia for direct production of isobutanol from cellulosic biomass.

Authors:  Jeremy J Minty; Marc E Singer; Scott A Scholz; Chang-Hoon Bae; Jung-Ho Ahn; Clifton E Foster; James C Liao; Xiaoxia Nina Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

5.  Effect of glucose supply strategy on acetate accumulation, growth, and recombinant protein production by Escherichia coli BL21 (lambdaDE3) and Escherichia coli JM109.

Authors:  J Shiloach; J Kaufman; A S Guillard; R Fass
Journal:  Biotechnol Bioeng       Date:  1996-02-20       Impact factor: 4.530

6.  Replacement of the glucose phosphotransferase transport system by galactose permease reduces acetate accumulation and improves process performance of Escherichia coli for recombinant protein production without impairment of growth rate.

Authors:  Ramón De Anda; Alvaro R Lara; Vanessa Hernández; Verónica Hernández-Montalvo; Guillermo Gosset; Francisco Bolívar; Octavio T Ramírez
Journal:  Metab Eng       Date:  2006-03-06       Impact factor: 9.783

7.  Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene.

Authors:  Jennifer R Anthony; Larry C Anthony; Farnaz Nowroozi; Gina Kwon; Jack D Newman; Jay D Keasling
Journal:  Metab Eng       Date:  2008-08-12       Impact factor: 9.783

8.  Effects of the presence of ColE1 plasmid DNA in Escherichia coli on the host cell metabolism.

Authors:  Zhijun Wang; Li Xiang; Junjie Shao; Alicja Wegrzyn; Grzegorz Wegrzyn
Journal:  Microb Cell Fact       Date:  2006-11-17       Impact factor: 5.328

9.  Distributing a metabolic pathway among a microbial consortium enhances production of natural products.

Authors:  Kang Zhou; Kangjian Qiao; Steven Edgar; Gregory Stephanopoulos
Journal:  Nat Biotechnol       Date:  2015-01-05       Impact factor: 54.908

10.  Insights into mutualism mechanism and versatile metabolism of Ketogulonicigenium vulgare Hbe602 based on comparative genomics and metabolomics studies.

Authors:  Nan Jia; Ming-Zhu Ding; Jin Du; Cai-Hui Pan; Geng Tian; Ji-Dong Lang; Jian-Huo Fang; Feng Gao; Ying-Jin Yuan
Journal:  Sci Rep       Date:  2016-03-16       Impact factor: 4.379

View more
  3 in total

1.  Reconstruction of amino acid biosynthetic pathways increases the productivity of 2-keto-L-gulonic acid in Ketogulonicigenium vulgare-Bacillus endophyticus consortium via genes screening.

Authors:  Cai-Hui Pan; En-Xu Wang; Nan Jia; Xiu-Tao Dong; Yu Liu; Ming-Zhu Ding; Ying-Jin Yuan
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-10       Impact factor: 3.346

Review 2.  The industrial versatility of Gluconobacter oxydans: current applications and future perspectives.

Authors:  Gabrielle Alves Ribeiro da Silva; Simone Santos de Sousa Oliveira; Sara Fernandes Lima; Rodrigo Pires do Nascimento; Andrea Regina de Souza Baptista; Sorele Batista Fiaux
Journal:  World J Microbiol Biotechnol       Date:  2022-06-11       Impact factor: 4.253

3.  Comparative genomics and metabolomics analyses of the adaptation mechanism in Ketogulonicigenium vulgare-Bacillus thuringiensis consortium.

Authors:  Nan Jia; Ming-Zhu Ding; Yang Zou; Feng Gao; Ying-Jin Yuan
Journal:  Sci Rep       Date:  2017-04-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.